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Abstract

This study aimed to assess the hypothesis that the growth factor receptor c-kit
regulates apoptosis in the prepubertal mouse ovary. Employing an in vivo mouse model,
c-kit translation was locally blocked by intra-ovarian bursal injection of oligonucleotides
antisense to c-kit in 20-day-old gonadotropin primed female mice. Effects of the
antisense treatment were assessed using DNA fragmentation analysis and the terminyl
deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) technique and
compared to effects of missense oligonucleotide treatment. DNA laddering, a hallmark
of apoptosis, was induced in ovaries by the c-kit antisense treatment six hours post¬
treatment and was significant compared to minimal laddering induced six hours
following missense treatment. No significant differences between treatment groups were
observed 2, 4, 8, 18, and 24 hours following treatment. To determine whether these
results could be confirmed by an alternative method of apoptosis detection, the in situ
TUNEL technique was applied, however a functional assay could not be established. The
results of this study indicate that apoptosis may be induced in prepubertal mouse ovaries
six hours following local blockade of c-kit using antisense oligonucleotides, although
confirmatory studies are required.
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1.

Introduction

The c-kit growth factor receptor functions as an essential but uncharacterized
regulator of mammalian ovarian follicle development. C-kit is a proto-oncogene at the
White spotting (W) locus on mouse chromosome 5 and human chromosome 4 and
encodes a transmembrane tyrosine kinase receptor that is a member of the platelet-derived
growth factor receptor subfamily. *

The ligand for the receptor is a glycoprotein termed

kit ligand (KL),4 steel factor (S1F), stem cell factor (SCF),5’6 and mast cell growth factor
(MGF), ’ and is encoded at the Steel (SI) locus on mouse chromosome 10 and human
chromosome 12.3'9-11 The significance of c-kit in oocyte development was recognized
when mutations in the loci encoding c-kit or its ligand resulted in defects in
gametogenesis in mice.1,9’10’12 Mice with double dose mutations at either the W or SI
loci generally exhibit sterility, in addition to hypoplastic anemia, mast cell deficiency, and
cutaneous melanocyte deficiency.9,10 The sterility in females with Steel loci mutations is
manifest by a decrease in oocyte number and developmental arrest at the one-layer
follicular stage.

It has since been established that KL and c-kit are important regulators

in embryonic oogenesis and that KL is required for the in vitro survival and proliferation
of primordial follicular cell complexes in culture.13'16 Further, blockade of c-kit function
in utero, through the administration of a c-kit specific antibody, results in severely
impaired early development of existing primordial follicles in fetal and neonatal mice.17’19

Throughout development, it appears that the level of c-kit and KL expression in
the ovary correlates with the rate of oocyte growth. C-kit and KL expression is highest in
oocytes that are growing rapidly and is lowest in oocytes where growth has been
suspended or has ceased. ’

C-kit mRNA is first detected at low levels in primordial

germ cells as early as 8 days post coitum and at increasing levels in germ cells as they
migrate to the genital ridge and differentiate into male and female gonads.

During the

perinatal period, most oocytes have entered the quiescent prophase stage of meiosis, and
c-kit expression is no longer detectable.20,21 In the postnatal ovary, expression of KL and
c-kit resumes in the central developing portion of the ovary. By postnatal day 5, growing
1- and 2-layer follicles demonstrate high levels of c-kit and KL expression which
progressively increases in growing follicles up to day 17. ’

Thereafter, KL expression

is limited to the outer rim of multi-layer follicles. In atretic follicles, c-kit and KL
21

expression fall to minimal levels.

These temporal expression patterns of c-kit and KL

correspond to their function in postnatal folliculogenesis. Stepwise in vivo antibody
blockade of c-kit function in newborn and juvenile mice significantly impairs primordial
follicle development, primary follicle growth, follicular fluid formation, and preovulatory
follicle maturation.24
In the postnatal ovary, oocytes and thecal cells have been shown to express the c21 23 25 27

kit receptor while granulosa cells and stromal derived cells express KL. ’

’

In vitro

oocyte growth of follicles derived from juvenile mice is stimulated by KL in a dose
dependent manner.
blocking antibody.

28

Further, growth of oocytes in vitro is inhibited by a functional c-kit
Thecal cells in bovine follicular cultures are also stimulated by the
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addition of KL which results in cell growth, development, and steroid production.

26

C-kit

and KL may therefore mediate a signaling pathway between oocytes, granulosa cells, and
thecal cells in growing and developing follicles in the postnatal ovary. It is likely that
KL, produced by granulosa cells, acts as an oocyte and thecal cell growth factor by
phosphorylating downstream targets via the c-kit receptor, although the location and
function of these targets are not known.
Limited evidence suggests that activation of c-kit and KL may function to inhibit
apoptosis. Well established roles for apoptosis have been defined in ovarian prenatal
development and postnatal tissue homeostasis.

Apoptosis is as an active process of cell

death that is gene directed and occurs to fulfil a biological function.29’30 Morphological
features characterizing apoptosis include cell shrinkage, cytoplasm collapse, condensation
of chromatin, nuclear fragmentation, and membrane blebbing.29’31 Apoptosis can be
further distinguished from other forms of cell death by the characteristic activation of
intemucleosomal nucleases producing cleaved DNA fragments that are multiples of
approximately 185 basepairs in length.

32

The rapid prenatal attrition of female germ cells may be explained by the
induction of apoptosis due to an inadequate source of KL during the perinatal period.
This is supported by studies where apoptosis in cultured primordial germ cells or fetal
ovaries is repressed by the addition of KL.33,34 However, a role for c-kit in postnatal
follicular cell death and homeostasis has not been addressed. In the postnatal ovary, the
majority of follicles that undergo endocrine dependent development ultimately undergo
atresia and luteal regression following apoptosis in granulosa cells.31,35'37 In prepubertal
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rats stimulated with gonadotropins, apoptotic granulosa cells can be detected in atretric
follicles within 48 hours of treatment and by five days following treatment, all atretic
follicles demonstrate apoptotic granulosa cells.36 In adult rat ovaries, apoptosis in atretic
follicles can be observed in granulosa cells and occasional thecal cells throughout the
estrous cycle.36 All follicles may contain a program to undergo apoptosis and progression
toward ovulation may be due to constant suppression of apoptosis in follicular cells. The
presence or withdrawal of factors likely modulate the induction of apoptosis and
subsequent follicular atresia in the ovary. ’

For example, gonadotropin withdrawal in

rats using an in vivo treatment of an anti-equine chorionic gonadotropin antibody rapidly
induces apoptosis in antral follicles.

Factors which have been proposed to modulate

apoptosis in the ovary include epidermal growth factor, transforming growth factor a,
basic fibroblast growth factor, insulin like growth factor I, keratinocyte growth factor,
hepatocyte growth factor, vasoactive intestinal peptide, gonadotropin releasing hormone,
transforming growth factor B, tumor necrosis factor

a and dehydroepiandrosterone

(DHEA).35’36’39
Because apoptosis is a process under gene control, these potential regulatory
factors must function by up- or down-regulating specific apoptotic inducer and repressor
gene products.

One theory maintains that gonadotropins and other growth factors may

regulate apoptosis in the postnatal ovary by altering the balance of members of the bcl-2
gene family. Overexpression of bcl-2 in transgenic mice is associated with decreased
apoptosis in follicular cells and enhanced folliculogenesis.40 Specifically, gonadotropins
may inhibit apoptosis in the developing rat ovary by increasing levels of apoptosis
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suppressor genes bcl-2 and bcl-xshort, while decreasing levels of expression of apoptosis
inducer genes bax and bcl-xlong.41 Gonadotropins and other factors may alternatively
mediate apoptosis by modulating levels of the death inducer gene p53.42,43 Interestingly,
the mechanism of p53 mediated induction of apoptosis in the ovary may be via upregulation of the bax gene or down-regulation of the bcl-2 gene.42,44 Additionally,
increased levels of fas and fas ligand have been observed in mouse and rat atretic
follicular cells and may also be involved in the induction of apoptosis in the mammalian
ovary.

45-47

Although the mechanism and function of c-kit and KL have not been defined,
considerable evidence suggests that this ligand-receptor pair regulate the expression of
apoptotic inducer and/or repressor genes.33,48,49 In cultures of natural killer cells, the
addition of KL results in an up-regulation of the apoptotic suppressor gene product, bcl-2,
and a subsequent inhibition of apoptosis.49 KL also reversibly rescues IL-3-deprived
mast cells from apoptosis in vitro. However, in mast cells, KL does not inhibit apoptosis
by inducing the expression of bcl-2, but by down-regulating expression of the apoptotic
inducer gene product, bax.50'52 In Friend erythroleukemia cells, KL inhibits apoptosis via
suppression of a p53 mediated pathway.53 The observation that apoptosis is inhibited in
primordial germ cell cultures by the addition of KL supports the concept that c-kit and
KL function to repress apoptosis during oocyte development.33,34
Thus, an essential role for c-kit in prenatal and postnatal ovarian folliculogenesis
has been firmly established. While some evidence indicates that c-kit may function to
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inhibit apoptosis in natural killer cells, mast cells, and primordial germ cells, the
mechanism of function of c-kit in the postnatal mammalian ovary is not known.

7.

Statement of Purpose

This study was designed to determine if c-kit’s function in postnatal
folliculogenesis can be explained by repression of apoptosis in developing follicular cells.
To assess this, an in vivo mouse model was employed to assess the effects of blocking
ovarian c-kit expression by intra-ovarian bursal injection of oligonucleotides antisense to
murine c-kit cDNA. Apoptosis was subsequently assessed using DNA fragmentation
analysis as well as an in situ apoptotic detection methodology. The specific hypothesis
addressed is: Does in vivo blockade of c-kit function induce apoptosis in developing
prepurbertal mouse ovaries?

8.

Methods

All methods described below were planned, optimized, and performed by the
student independently with the exception of the mouse in vivo intra-ovarian bursal
injections which were performed jointly by the student and Dr. Hugh Taylor.

Oligonucleotides.
To block c-kit function in mouse ovaries in vivo, 25 base pair antisense
oligonucleotides were synthesized to target a region near the translation start codon of
murine c-kit mRNA corresponding to nucleotides 120-146.3 The sequence of the
antisense c-kit oligonucleotide was 5' GGA TGG ATG GCG GAG ACG GCT CCC C 3'.
This oligonucleotide sequence was selected based on its previously demonstrated
blockade of c-kit protein expression and function.54 When microinjected into rat oocytes,
this sequence significantly decreased cell-surface expression of c-kit and inhibited oocyte
germinal vesicle breakdown.54 To provide a control oligonucleotide treatment, all
nucleotides of the antisense oligonucleotides were synthesized in a random order to create
a missense oligonucleotide. The c-kit missense sequence was 5' CTG GCT GAC CTG
CCC CAC GTG GAC C 3'.54 Oligonucleotides were synthesized, phosphorothioate
modified, and OPC cartridge purified by the Program for Critical Technologies in
Molecular Medicine of the Yale University School of Medicine Department of Pathology.
Oligonucleotides were dried under vacuum and resuspended in sterile PBS at a
concentration of 600 pM.

9.

Animals and Surgical Procedure
Prepubertal CD-I female mice (Charles River Laboratories, Wilmington, MA) ranging
from twenty to twenty-three days of age were included in the study and maintained in
accordance with the guidelines of Yale Animal Care and Use Committee (YACUC).
Mice were anesthetized by intraperitoneal injection with a mixture of 100 mg/kg body
weight ketamine and 20 mg/kg xylazine provided by the Yale Animal Care Resources.
Ovaries were exposed by laparotomy using a ventral vertical incision and isolated under a
dissecting microscope. A method of intrabursal administration of DNA in rat ovaries
described by Piontkewitz et al. was adopted for this study.55 Twenty microliters of
600pM antisense or missense oligonucleotides in PBS were loaded into a 100-microliter
syringe (Hamilton Co., Reno, Nevada) and slowly injected through a 32 gauge needle into
the ovarian bursa of each ovary. Care was taken to inject the treatment in the space
between mesothelium surrounding the ovary and the ovarian surface and to avoid
puncture of the ovary. If the ovary was punctured and bleeding ensued the mouse was
marked and not included in the analysis. Both ovaries in each mouse received the same
treatment solution. Peritoneal and skin incisions were closed using fine sutures.

To

initiate follicular growth 90 minutes following surgery, mice received 5 IU of pregnant
mare’s serum gonadotropin (PMSG) (Sigma-Aldrich, St. Louis, MO) administered by
subcutaneous injection using tuberculin needles. One to 24 hours following gonadotropin
treatment ovaries were collected following anesthetization and repeat ventral laparotomy.
Following ovary collection and preparation, mice were sacrificed in accordance with the
guidelines of YACUC.
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DNA Extraction
Ovaries were dissected free from associated ovarian mesotheiium, fallopian tube and
adipose tissue. Ovaries were quickly cut into small pieces using a sterile disposable blade
and immediately frozen in polyethylene 2.0 ml cryotubes on dry ice. Genomic DNA was
extracted using the QIAamp Tissue Kit (Qiagen Inc., Santa Clarita, CA) according to the
manufacturer’s instructions. To obtain RNA-free genomic DNA, samples were digested
with RNAse A (DNAse free, Boehringer-Mannheim Corp.) at 10 pg/ml for 10 minutes at
room temperature either following tissue lysis or nucleic acid elution steps based on a
IQ

protocol adapted from Palumbo and Yeh, 1994.

The quality and purity of each nucleic

acid sample was determined by measuring optical densities at A260 and A280 nm.

DNA Fragmentation Analysis
A biochemical characteristic of apoptosis is the activation of an intracellular
endonuclease activity. This results in inter-nucleosomal cleavage of genomic DNA into
fragments of multiples approximately 185 base pairs in length. ’

Apoptosis can

therefore be detected by a distinctive ladder pattern following size fractionation by
agarose gel electrophoresis.

To analyze samples for DNA fragmentation, equal

quantities of purified RNA-free DNA (2 pg) of each sample were added to 4 pi gel
loading buffer and double distilled water to total 35 pi. Samples were electrophoresed on
1.8% agarose gels containing ethidium bromide (0.5 pg/ml) submerged in TAE buffer
(40mM Tris, 20 mM sodium acetate, 1 mM EDTA, pH 7.2) for 50 minutes at 90 V. Four
micrograms of a 123 base pair DNA ladder (GibcoBRL, Life Technologies, Inc.,

ll

Gaithersburg, MD) was run simultaneously for size comparison. Gels were visualized
and photographed on an UV transilluminator.

Histology
For morphological analysis, ovaries were isolated and removed in association with
surrounding mesothelium, tube, and adipose tissue. Ovaries were immediately placed in
cassettes (Tissue Tek) and fixed in 10% formalin overnight at 4°C. Ovaries were then
paraffin-embedded, sectioned 4-6 pm, and mounted on poly-L-lysine-coated slides as
routine by the Yale University School of Medicine Department of Surgical Pathology.
Sections were heated for 30 minutes at 60°C and deparaffinized through three 5-minute
washes of xylene, then rehydrated through 3-minutes washes of 100%, 90%, and 75%
ethanol, and two 1-minute washes in double distilled water. Sections were stained with
hematoxylin for 45 seconds, set in aqueous mounting medium (Crystal/Mount, Biomeda
Corp., Foster City, CA), and examined and photographed under a light microscope.
Follicle diameter was measured using a calibrated ocular micrometer. Follicles were
classified as small, medium, or large using the methodology described by Pedersen and
Peters, 1968.57

In situ apoptosis detection
DNA fragmentation distinctive of apoptosis was detected in situ by using a modified
protocol of the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling
(TUNEL) technique.

Apoptotic breaks in nuclear DNA were detected by labeling free

3’ OH ends of DNA with fluorescein modified nucleotides using terminal
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deoxynucleotidyl transferase.

58

To detect in situ apoptosis, a commercially available kit

was used with modifications of the manufacturer’s protocol (In Situ Cell Death Detection
Kit, Boehringer-Mannheim, Corp.). Ovaries were isolated and removed in association
with surrounding tissues as above and fixed in 10% formalin, 4% paraformaldehyde
(prepared from 16% stock solution) or 4% paraformaldehyde, pH 7.2, freshly prepared
from solid for 14, 1, 114, 6, or 12 hours at 4°C. Tissue was embedded in paraffin,
sectioned, mounted and deparaffinized as above. The assay was initially performed on
archival normal adult mouse ovary paraffin embedded sections to test the efficacy of the
technique. For proteolytic digestion, tissue was treated with 20 or 200 pg/ml proteinase
K (Sigma-Aldrich, St. Louis, MO; 10 mM TrisHCl, pH 7.6) for 30 minutes at room
temperature or 37°C. Additionally, some samples were permeabilized by treating with
0.5% Triton X-100 (Rohm & Haas, Philadelphia, USA) in 0.1% sodium citrate for 2
minutes on ice. To alternatively achieve proteolysis, tissue was subjected to 1-minute
microwave irradiation at 750 W (high) in 0.1 M citrate buffer, pH 6.0, followed by gentle
cooling and washing in PBS, pH 7.4.59 For samples that were labeled with horseradish
peroxidase (POD), endogenous peroxidase activity was blocked by incubating samples in
0.3% hydrogen peroxide in methanol for 20 minutes at room temperature. A hydrophobic
marker (Pap Pen, Research Products International Corp., Mount Prospect, IL) was used to
create a barrier encircling tissue. To reduce non-specific binding, samples were blocked
with 10% fetal bovine serum (FBS) for 30 minutes at room temperature and washed twice
with PBS. DNA fragments were 3’-OH-labeled using deoxynucleotidyl transferase
diluted 1:5 in a reaction buffer containing fluorescein modified nucleotides as directed by
the manufacturer or at additional dilutions of 1:10, 1:50, 1:100, 1:1,000 and 1:10,000. To
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label nuclear DNA, 35-50 pi of the enzyme/buffer solution was added to each tissue
section, coverslips were applied to avoid evaporative losses, and slides were incubated at
37°C for 30 minutes or 1 hour. Slides were washed with three 1-minute PBS washes.
Signal conversion of samples was achieved by applying 35-50 pi of a anti-fluorescein
antibody, fab fragment from sheep, conjugated with alkaline phosphatase (AP) or
horseradish peroxidase (POD) non-diluted or at a 1:2 or 1:5 dilution in blocking solution.
Coverslips were applied and slides were incubated at 37°C for 30 minutes, then washed
three times with PBS. To develop sections labeled with AP, slides were flooded with an
AP developing solution (Histomark, Ph Thalo Red Solution, Kirkegaard & Perry
Laboratories, Inc., Gaithersburg, MD) prepared according to the manufacturer’s
instructions and incubated for 10 minutes at room temperature and then washed in
distilled water. To develop sections labeled with POD, a DAB/metal concentrate
(Boehringer Mannheim Corp.) was prepared at a 1:10 dilution in peroxide buffer
(Boehringer-Mannheim Corp.), applied to slides for 30-90 seconds after which the
reaction was stopped by washing slides in distilled water. Slides were counterstained,
mounted, and visualized as above. To prepare a positive control, DNA nicks with free
3’OH ends were induced by treating tissue with 1 mg/ml DNAse I (BoerhingerMannheim, Inc.; 1 mg/ml BSA, 1 mM MgCfr, 50mM TrisHCl, pH 7.5) for 10 minutes at
room temperature. Substitution of the TdT enzyme with buffer solution served as a
negative control.

14.

Results

Effect of RNAse treatment on DNA Fragmentation Analysis
Non-RNA-free DNA was extracted from ovaries collected 6 and 18 hours
following in vivo intrabursal treatment with c-kit antisense (AS-6h, AS-18h) or missense
(MS-6h, MS-18h) oligonucleotides and PMSG priming without RNAse treatment. Ratios
of optical densities at A260 and A280 ranged from 1.605 to 1.851 and confirmed purity
of nucleic acid samples. DNA (2 pg) from each sample was fractionated by
electrophoresis for DNA fragmentation analysis. In all fractionated DNA samples, a
nucleic acid smear with weak laddering was observed (Figure 1). To determine if nucleic
acid smear was attributable to an overlay of RNA, 2 pg each of MS-6h, MS-18h, and AS18h DNA was treated with RNAse. The RNAse-treated samples were then
electrophoresed simultaneously with an additional 2 pg of MS-6h DNA that was not
treated with RNAse. The nucleic acid smear present in the non-RNAse-treated MS-6h
DNA was absent in the RNAse treated MS-6h DNA and in the RNAse-treated MS-18h
and AS-18h DNA (Figure 2). Laddering was visible in the AS-18h DNA, and weakly
visible in the MS-18h DNA. The size of the DNA fragments was estimated to be 1.5
times the length of the simultaneously run 123 base pair DNA ladder fragments or
approximately 185 base pairs.
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DNA fragmentation analysis 6, 18, and 24 hours post treatment
DNA extracted from ovaries 6, 18, or 24 hours following antisense (AS) or
missense (MS) oligonucleotide treatment was purified of RNA through RNAse treatment.
2 pg of each RNA-free DNA sample was fractionated by electrophoresis for
fragmentation analysis. Strong laddering was observed in AS-6h DNA, less strong
laddering in the AS-18 h DNA, and weak laddering in AS-24h and all MS treated ovarian
DNA (Figure 3).

DNA fragmentation analysis 2, 4, and 8 /tours post treatment
To further define the time course of DNA fragmentation following treatments,
DNA was extracted from ovaries 2, 4, and 8 h following AS or MS oligonucleotide
treatment. RNAse was added to ovarian tissue samples following proteolysis but prior to
DNA purification and elution to increase yield. 2 pg of DNA was fractionated by
electrophoresis. At 2h, both MS and AS treated ovaries demonstrated strong laddering,
although laddering of AS-2h was slightly more pronounced than MS-2h (Figure 4).
Weak laddering was observed in all other DNA, however MS-4h laddering was slightly
less than MS-8h and AS-4h, and laddering in AS-8h was slightly greater than AS-4h.
DNA fragmentation analysis in untreated mice or mice treated with PBS alone were not
conducted and therefore these results are unavailable for comparison.

123bp

MS

MS

MS

AS

123 bp

AS

MS

MS

MS

12

3

AS

4

Figure 1. Fractionated DNA purified from ovaries

Figure 2. Fractionated DNA purified from

6 or 18 h post MS or AS treatment without RNAse

ovaries 6 or 18 h post MS or AS treatment.
Lane 1: no RNAse. Lane 2-4: RNA-free DNA.

Treatment. 2 ug DNA per lane.

2 ug DNA per lane.
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Figure 3. RNA-free DNA purified from ovaries

Figure 4. RNA-free DNA purified from ovaries

6, 18, or 24 h post MS or AS treatment.

2, 4, or 8 h post MS or AS treatment.

2 ug DNA per lane.

2 ug DNA per lane.

In situ detection of apoptosis by TUNEL technique
To detect apoptosis in situ, the TUNEL technique was applied to paraffin embedded
sections of ovaries 6, 18, and 24 hours following AS and MS oligonucleotide treatment.
Initially, to test the efficacy of the technique, TUNEL was applied to archival paraffinembedded mouse ovarian tissue. In this tissue, staining was specific to nuclei of
granulosa cells near the antrum of a large atretic follicle indicative of a functional assay
(Figure 8). Also, no staining was observed in the negative control and nuclei were
stained in the positive control (DNAse-treated) slide, indicative of an efficacious
technique (not shown). However, efficacy of the technique could not be demonstrated
when repeated in the experimental antisense and missense treated ovarian tissue and high
background unspecific staining was consistently observed. Figure 5 demonstrates this
diffuse non-specific TUNEL nuclear staining in MS-18h treated ovaries fixed in formalin
and developed with POD/DAB although some preferential staining of granulosa cells can
be discerned. However, no differences in staining were seen in the similarly processed
AS-18h treated ovaries shown in Figure 6 and Figure 7 (higher magnification). A
methodical trouble shooting approach was undertaken to test effects on fixation, enzyme
concentration, converter concentration, and developing method. However, a functional
non-specific TUNEL assay could not be established. The best of all protocols tested
employed an alternative proteolysis using microwave irradiation and citrate buffer as
shown in MS-24h treated ovaries in Figure 9. Using this protocol, increased staining of
granulosa cells of some follicles was observed, but background nuclear staining persisted
(Figure 9).
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Morphology
Paraffin embedded, hematoxylin stained, 4-6 (am sections of ovaries 6, 18, and 24 hours
following AS and MS oligonucleotide treatment were examined for morphology under a
light microscope. No differences in gross ovarian morphology, follicular development, or
follicular diameter were observed between ovaries treated with MS and AS
oligonucleotides. Figure 5 (MS-18h) and Figure 6 (AS-18h) demonstrate these findings.
By 24 h, no atretric follicles were observed in either treatment group. Electron
microscopy is beyond the scope of this project and therefore morphological evidence of
apoptosis could not be assessed.

20.

Discussion

In this study, local blockade of c-kit translation in ovaries of gonadotropin primed
mice was performed to characterize the role, if any, of c-kit in the mediation of apoptosis
in developing postnatal ovarian follicles. By directly adapting the treatment protocol
from prior published reports, the efficacy of c-kit blockade was assumed but not directly
examined. The sequence used to synthesize oligonucleotides antisense to mouse c-kit
cDNA in the present study had been previously shown by Ismail et al to impair the
surface expression of c-kit when injected into rat oocytes.54 Further, antisense treatment
impaired a presumable c-kit-mediated function in meiosis resumption.54 Additionally,
the missense treatment had no effect on c-kit expression or function.54 The c-kit
antisense oligonucleotides used in this study and in the present study were synthesized to
target the start region of mouse c-kit mRNA which is highly conserved in rats.3,5,54 The
route of administration differed in the present study and was not intracellular. Because
the goal in the present study was to examine the effects of local c-kit blockade in the
ovary, an intra-ovarian bursal administration was used. The intrabursal technique
employed was directly adapted from work by Piontkewitz et al where expression and
function of CCAAT enhancer binding protein-a was effectively blocked when
oligonucleotides antisense to that cDNA message were injected into rat ovarian bursas in
vivo.?;> The Piontkewitz et al study is the only one to demonstrate effective local
blockade of mRNA expression in the mammalian ovary using antisense oligonucleotides.
Therefore, the intra-bursal administration of oligonucleotides was adapted for the present
study, as opposed to alternative and undocumented possible methods of intraperitoneal,
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intravenous, or intra-ovarian injection of oligonucleotides. The present study is limited
by a lack of direct evidence that the treatment impaired c-kit translation. While
speculation that c-kit expression and function are impaired in the current model is
reasonable, a direct examination of the time course of c-kit expression and potential
blockade in response to treatment are needed. In aims to study the time-course response
of c-kit protein expression following putative c-kit mRNA translation blockade,
considerable efforts were undertaken to establish a functional immunohistochemistry
methodology specific for murine c-kit. These efforts, however, were unsuccessful. As an
alternative method to evaluate putative blockade of c-kit, efforts are now in progress to
apply the reverse-transcriptase-polymerase chain reaction to amplify c-kit transcripts in
ovaries following treatment with antisense and missense c-kit oligonucleotides.
Successful quantification of c-kit mRNA transcripts following treatments would provide
evidence to assess the efficacy of c-kit blockade as well as provide an assessment of the
time-course of c-kit down-regulation. To further validate the efficacy of c-kit blockade,
the present study would benefit from studies to localize the cellular targets of the
antisense and missense oligonucleotide treatments. This could be easily achieved by
labeling the oligonucleotides with an identifiable label, such as biotin, and performing
immunohistochemistry using an anti-biotin antibody to verify distribution of
oligonucleotides within the ovarian tissue.
The DNA fragmentation analyses suggest that the antisense oligonucleotide
treatment is associated with increased levels of apoptosis in gonadotropin primed mouse
ovaries. When DNA of treated ovaries was purified and fractionated by electrophoresis,
evidence of apoptosis was established by the distinctive laddering pattern made by

intemucleosomal fragments of multiples of 185 base pairs in length. Six hours following
the antisense treatment, strong laddering of DNA was observed, and this was less intense
but significant at 18 hours, and minimal by 24 hours. In contrast, weak laddering was
observed at 6, 18, and 24 hours following missense treatment. These findings were
consistent with the hypothesis that blockade of c-kit removed apoptosis suppression.
However, when this experiment was repeated to examine the time-course effect around
six hours, insignificant differences were observed between antisense and missense
treatments at 2, 4, and 8 hours following treatment. Further, significant laddering was
observed at 2 hours following both antisense and missense treatment. These findings
raise the concern that apoptosis could be induced by the trauma of the intrabursal
injection procedure or by non-specific effects of oligonucleotide treatment. It is therefore
imperative that these experiments be repeated with the inclusion of a non-treated control
and a vehicle (PBS) only control to assess the possible confounding affects of the
treatment technique. However, it is also possible that differences in levels of apoptosis
can not be discerned using a qualitative DNA fragmentation assay. It therefore may be
necessary to quantify DNA fragmentation using 3’ terminal transferase to attach a
quantifiable label, such as radioactive dideoxynucleotides, to free 3’ hydroxyl DNA
termini.40,46’60 Further, while c-kit blockade could potentially affect apoptosis in all
ovarian cell types, it may be necessary to dissect oocyte and granulosa follicular cells
from thecal cells to enable the detection small quantifiable effects in DNA laddering in
specific cell populations that cannot be appreciated in the examination of the total
genomic DNA of whole ovaries.

The time course of c-kit function in relation to PMSG-priming warrants further
exploration in this study. Levels of c-kit and KL mRNA and protein expression correlate
with primordial germ cell growth during prenatal development, and with oocyte and
follicular cell growth during postnatal follicle development. In the postnatal ovary, an
increase in c-kit and KL expression is seen in follicles progressing from primordial to
large growing antral follicles. However, little or no expression is observed in atretic
follicles. ’

Further, c-kit appears to play an essential function in early follicular

development as follicles in mice bearing the Steel panda mutations are arrested at the onelayer cuboidal stage.

In this study, treatment to block c-kit expression was given to

prepubertal mice primed with PMSG shortly following treatment to initiate development
in a large cohort of primordial follicles. Thus, the effect of blocking c-kit expression on
apoptosis could be assessed in early postnatal follicle growth assuming that c-kit function
is important soon after PMSG-priming. A prior study demonstrated that intraperitoneal
injection of a c-kit functional blocking antibody induces follicular atresia and ovulation
failure when administered 12 and 24 hours before gonadotropins but not when injected
earlier or later.24 While the present study provides some evidence for inhibition of
apoptosis in ovaries 6 hours following oligonucleotide treatment, it is not known whether
c-kit expression is in fact effectively blocked at that time-point.

The intrabursal

technique of administering oligonucleotides antisense to C/EBPa protein by Piontkewitz
et al included gonadotropin priming 2 hours following surgery. They were able to
demonstrate decreased C/EBPa protein 24 and 48 hours following surgery as well as an
effect of the antisense treatment on follicle development.55 The Ismail et al study where
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antisense and missense mouse c-kit oligonucleotides were injected directly into rat
oocytes, demonstrated decreased oocyte surface c-kit protein expression at 4 hours
following treatment and enhanced meiosis resumption at 20-24 hours following
treatment. In the present study, the effects of c-kit blockade using intrabursal injection of
antisense oligonucleotides were presumed to occur between 4 and 24 hours based on
these related studies. However, without direct examination the efficacy and time-course
of the treatment-induced blockade of c-kit expression, interpretation of DNA
fragmentation analyses at 2, 4, 6, 18, and 24 hours is limited. Therefore, an examination
of the time-course of c-kit mRNA expression and blockade following the oligonucleotide
treatment and PMSG priming is essential and would allow correlation of blockade of ckit expression with effects, if any, on apoptosis.
Also important to note are the potential confounding effects of gonadotropins on
c-kit expression. One study of 6-week-old female mice demonstrated a substantial
reduction of c-kit RNA levels in thecal cells 90 minutes following intraperitoneal
injection of 5 IU PMSG. Thecal cell c-kit RNA was undetectable by 4 hours following
PMSG and remained undetectable at 8 and 45 hours. PMSG had no effect on oocyte c-kit
RNA expression. In the present study, inhibition of c-kit expression may have been
mediated by PMSG, therefore negating attempts to study the specific effect of blocking ckit using oligonucleotides antisense to c-kit. Further, the 5 IU dose of PMSG used is
recommended for adult mice and may represent a supraphysiologic dose in 20-day-old
mice. Thus, the strong DNA laddering observed 2 hours following surgery in both AS
and MS oligonucleotide groups may in part be explained by a gonadotropin-mediated
inhibition of c-kit expression in both the treatment and control groups and subsequent
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loss of c-kit suppression of apoptosis. However, physiological levels of gonadotropins
are not associated with the induction of apoptosis in the mammalian ovary. Rather,
withdrawal of gonadotropin support is associated with the induction of apoptosis in
granulosa cells and follicular atresia. ’

Subsequent study of the effects of c-kit

antisense oligonucloetide treatment in the absence of PMSG should be conducted to
remove the confounding effects of exogenous gonadotropins.
Ultimately, assessment of apoptosis induction by a methodology in addition to
DNA fragmentation analysis would be helpful in assessing validity of results. In this
study, considerable efforts were taken to establish a protocol to detect apoptosis in situ
using the TUNEL technique. Unfortunately, after manipulation of each step in the
protocol and consultation with experienced researchers, a functional assay could not be
developed. Additionally, it was planned to include an analysis of effects of antisense ckit oligonucleotide treatment on the expression of apoptosis markers through Northern
analysis of extracted RNA. As in vitro evidence in other cell lineages suggests that c-kit
may regulate bcl-2, bax, or p53 expression, examining mRNA levels of these apoptotic
markers after of blocking c-kit in vivo could provide useful quantifiable data regarding ckit function in the ovary.49’53
In summary, the findings of this study indicate that induction of apoptosis in
prepubertal mouse ovaries may be induced by the intra-bursal administration of c-kit
antisense oligonucleotides and that this effect may be maximal six hours following
treatment.

Confirmatory evidence for these findings was not demonstrated, and therefore

future studies are necessary to adequately assess the validity of the hypothesis that c-kit
inhibits apoptosis in the post-natal mouse ovary. To validate the efficacy of the treatment
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method, studies using reverse-transcriptase polymerase chain reaction should be
performed to determine whether c-kit mRNA expression is down-regulated following
treatment with antisense but not missense oligonucleotides. Further, c-kit mRNA
expression following oligonucleotide treatment should be quantified at time-points
between 4 and 48 hours to describe the time-course of the effects of the treatment and
allow correlation with possible effects on apoptosis. Interpretation of DNA
fragmentation analysis could be facilitated by labeling DNA fragments and quantifying
the amounts of laddering induced by c-kit antisense compared to missense
oligonucleotide treatment. To remove possible confounding effects of gonadotropins,
DNA fragmentation analysis could be performed in ovaries treated in vivo with c-kit
antisense oligonucleotides in the absence of PMSG. Finally, an alternative method to
evaluate the effects of c-kit blockade on apoptosis in the ovary could be employed to
validate the results, as efforts to utilize the TUNEL technique for this purpose proved
unsuccessful. To this end, levels of apoptosis related gene products bcl-2, bax, and p53
could be isolated and quantified by RNA extraction and Northern analyses and compared
between c-kit antisense and missense oligonucleotide treated ovaries. Pursuit of the
proposed future studies may further assess the hypothesis posed in the present research
and elucidate the mechanism of c-kit function in the post-natal mammalian ovary.
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